Completed PHASE2 INTERVENTIONAL 1-arm NCT00607997

Study of Voreloxin (Vosaroxin) in Older Patients With Untreated Acute Myeloid Leukemia

A Phase 2, Open-Label, Multicenter Clinical Study of the Safety and Efficacy of Voreloxin (Vosaroxin) Injection in Patients Equal to or Greater Than 60 Years of Age With Previously Untreated Acute Myeloid Leukemia

Sponsor: Sunesis Pharmaceuticals

Conditions Acute Disease Acute Myeloid Leukemia Leukemia Myelodysplastic Syndromes Nonlymphocytic Leukemia

Interventions vosaroxin

Updated 8 times since 2017 Last updated: May 25, 2017 Started: May 15, 2008 Primary completion: Nov 30, 2009 Completion: Nov 23, 2009

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00607997, this PHASE2 trial focuses on Acute Disease and Acute Myeloid Leukemia and remains completed. Sponsored by Sunesis Pharmaceuticals, it has been updated 8 times since 2008, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Dec 2021 — Jul 2024 [monthly]

Completed PHASE2
Jan 2021 — Dec 2021 [monthly]

Completed PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2

▶ Show 3 earlier versions

Aug 2017 — Jun 2018 [monthly]

Completed PHASE2
Feb 2017 — Aug 2017 [monthly]

Completed PHASE2
Jan 2017 — Feb 2017 [monthly]

Completed PHASE2

First recorded

May 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Sunesis Pharmaceuticals

Data source: Sunesis Pharmaceuticals

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Boston, United States , Charleston, United States , Chicago, United States , Columbia, United States , Denver, United States , Houston, United States , Indianapolis, United States , Jackson, United States , La Jolla, United States , Nashville, United States and 6 more locations